Still, the risks are stark. NioCorp has no revenue, a trailing net loss, and a beta of just 0.17, which suggests the stock does not move in lockstep with broader markets. The 52‑week range shows that the shares have traded as high as $12.58 and as low as $2.64, meaning the current price is closer to the low end of that band despite the 75% rally. A TrendMatrix model flagged a “Sell” verdict with a score of 5.5/10, citing quality‑floor failures and capitulation‑risk momentum, while noting that a rising 200‑day moving average and a large analyst upside gap keep the speculative case alive.
The 75% return reported by Investing.com captures a moment when fair‑value analysis and critical‑mineral enthusiasm converged. Yet the after‑market drop following a positive earnings surprise, the absence of revenue, and the wide dispersion in analyst targets all point to a market that is pricing hope rather than hard milestones. The question now is whether NioCorp can convert policy tailwinds and project potential into tangible permitting and financing progress before the fair‑value narrative loses its grip.
Sources: Source 1 · Source 2 · Source 3 · Source 4 · Source 5 · Source 6
